Roffman Miller Associates’s Amgen AMGN Stock Holding History

Roffman Miller Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,323	Closed	-$1.73M	–	79
2020 Q2	$1.73M	Buy	+7,323	New	+$1.67M	0.17%	60

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Roffman Miller Associates's AMGN Position: Q3 2020 in Review

Roffman Miller Associates sold out of Amgen (AMGN) in Q3 2020, closing a stake of 7,323 shares — an estimated $1.73M sold.

Roffman Miller Associates first reported a position in AMGN in Q2 2020 and held it in 1 quarter. The position peaked at $1.73M in Q2 2020. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

Roffman Miller Associates reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
Roffman Miller Associates sold 7,323 Amgen shares in Q3 2020, an estimated $1.73M.
Roffman Miller Associates first reported a position in Amgen in Q2 2020 and held it in 1 quarter.
Roffman Miller Associates's Amgen position peaked at $1.73M in Q2 2020.
2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Roffman Miller Associates's 13F filing for Q3 2020, filed 6 Nov 2020.